Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Journal of the American Society of Nephrology : JASN
|
October 12, 2017
ShcA Adaptor Protein Promotes Nephrin Endocytosis and Is Upregulated in Proteinuric Nephropathies
Claire E Martin, Kelly A Petersen, Lamine Aoudjit, et al.
The EMBO Journal
|
February 15, 2008
ShcA signalling is essential for tumour progression in mouse models of human breast cancer
Josie Ursini-Siegel, W Rod Hardy, Dongmei Zuo, et al.
Plos One
|
December 11, 2012
The adaptor protein Grb2 is not essential for the establishment of the glomerular filtration barrier
Nicolas Bisson, Julie Ruston, Marie Jeansson, et al.
Cancer Research
|
May 23, 2013
The ShcA PTB domain functions as a biological sensor of phosphotyrosine signaling during breast cancer progression
Ryuhjin Ahn, Valerie Sabourin, Jacqueline R Ha, et al.
Cancer Science
|
May 29, 2026
Oncogenic BRAF and KRAS Promote Global DNA Hypomethylation Through a Directed Pathway That Upregulates TET3
Ichiro Onoyama, W Rod Hardy, Shoichiro Takeishi, et al.
The Lancet. Infectious Diseases
|
April 8, 2023
Differential serum neutralisation of omicron sublineages in patients receiving prophylaxis with tixagevimab-cilgavimab
Javier T Solera, Berta G Arbol, Victor H Ferreira, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 28, 2023
Omicron BA.4/5 Neutralization and T-Cell Responses in Organ Transplant Recipients After Booster Messenger RNA Vaccine: A Multicenter Cohort Study
Victor H Ferreira, Matthew Ierullo, Faranak Mavandadnejad, et al.
Nature
|
July 13, 2013
Temporal regulation of EGF signalling networks by the scaffold protein Shc1
Yong Zheng, Cunjie Zhang, David R Croucher, et al.
Nature Communications
|
August 4, 2022
Homotypic and heterotypic immune responses to Omicron variant in immunocompromised patients in diverse clinical settings
Victor H Ferreira, Javier T Solera, Queenie Hu, et al.
Nature Communications
|
September 27, 2023
Omicron variant neutralizing antibodies following BNT162b2 BA.4/5 versus mRNA-1273 BA.1 bivalent vaccination in patients with end-stage kidney disease
Kevin Yau, Alexandra Kurtesi, Freda Qi, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Journal of the American Society of Nephrology : JASN
|
October 12, 2017
ShcA Adaptor Protein Promotes Nephrin Endocytosis and Is Upregulated in Proteinuric Nephropathies
Claire E Martin, Kelly A Petersen, Lamine Aoudjit, et al.
The EMBO Journal
|
February 15, 2008
ShcA signalling is essential for tumour progression in mouse models of human breast cancer
Josie Ursini-Siegel, W Rod Hardy, Dongmei Zuo, et al.
Plos One
|
December 11, 2012
The adaptor protein Grb2 is not essential for the establishment of the glomerular filtration barrier
Nicolas Bisson, Julie Ruston, Marie Jeansson, et al.
Cancer Research
|
May 23, 2013
The ShcA PTB domain functions as a biological sensor of phosphotyrosine signaling during breast cancer progression
Ryuhjin Ahn, Valerie Sabourin, Jacqueline R Ha, et al.
Cancer Science
|
May 29, 2026
Oncogenic BRAF and KRAS Promote Global DNA Hypomethylation Through a Directed Pathway That Upregulates TET3
Ichiro Onoyama, W Rod Hardy, Shoichiro Takeishi, et al.
The Lancet. Infectious Diseases
|
April 8, 2023
Differential serum neutralisation of omicron sublineages in patients receiving prophylaxis with tixagevimab-cilgavimab
Javier T Solera, Berta G Arbol, Victor H Ferreira, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 28, 2023
Omicron BA.4/5 Neutralization and T-Cell Responses in Organ Transplant Recipients After Booster Messenger RNA Vaccine: A Multicenter Cohort Study
Victor H Ferreira, Matthew Ierullo, Faranak Mavandadnejad, et al.
Nature
|
July 13, 2013
Temporal regulation of EGF signalling networks by the scaffold protein Shc1
Yong Zheng, Cunjie Zhang, David R Croucher, et al.
Nature Communications
|
August 4, 2022
Homotypic and heterotypic immune responses to Omicron variant in immunocompromised patients in diverse clinical settings
Victor H Ferreira, Javier T Solera, Queenie Hu, et al.
Nature Communications
|
September 27, 2023
Omicron variant neutralizing antibodies following BNT162b2 BA.4/5 versus mRNA-1273 BA.1 bivalent vaccination in patients with end-stage kidney disease
Kevin Yau, Alexandra Kurtesi, Freda Qi, et al.
Page
of 3